CA3065683A1 - Method for producing optically active compound - Google Patents
Method for producing optically active compound Download PDFInfo
- Publication number
- CA3065683A1 CA3065683A1 CA3065683A CA3065683A CA3065683A1 CA 3065683 A1 CA3065683 A1 CA 3065683A1 CA 3065683 A CA3065683 A CA 3065683A CA 3065683 A CA3065683 A CA 3065683A CA 3065683 A1 CA3065683 A1 CA 3065683A1
- Authority
- CA
- Canada
- Prior art keywords
- group
- optionally substituted
- salt
- acid
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2017-106280 | 2017-05-30 | ||
| JP2017106280 | 2017-05-30 | ||
| PCT/IB2018/053822 WO2018220533A2 (ja) | 2017-05-30 | 2018-05-29 | 光学活性化合物の製造法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3065683A1 true CA3065683A1 (en) | 2018-12-06 |
Family
ID=64454503
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3065683A Pending CA3065683A1 (en) | 2017-05-30 | 2018-05-29 | Method for producing optically active compound |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US10988469B2 (https=) |
| EP (2) | EP3632441B1 (https=) |
| JP (2) | JP7102233B2 (https=) |
| KR (1) | KR102754527B1 (https=) |
| CN (2) | CN111032047B (https=) |
| AU (1) | AU2018276192B2 (https=) |
| CA (1) | CA3065683A1 (https=) |
| EA (1) | EA039880B1 (https=) |
| ES (1) | ES2986461T3 (https=) |
| IL (1) | IL270983B (https=) |
| MX (1) | MX391164B (https=) |
| WO (1) | WO2018220533A2 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX391164B (es) | 2017-05-30 | 2025-03-21 | Dot Therapeutics 1 Inc | Metodo para producir compuesto opticamente activo |
| CN113557227A (zh) * | 2019-03-27 | 2021-10-26 | 协和医药化工股份有限公司 | 前列腺素的制造方法 |
| AU2021376286A1 (en) * | 2020-11-06 | 2023-06-22 | Dana-Farber Cancer Institute, Inc. | Raf inhibitor for treating low grade glioma |
| CN114685564B (zh) * | 2020-12-27 | 2023-09-22 | 西北大学 | 新型亚磷酰胺配体及其合成方法和应用 |
| EP4377296A1 (en) | 2021-07-26 | 2024-06-05 | Arvinas Operations, Inc. | Methods of manufacturing a bifunctional compound |
| CN117567388B (zh) * | 2023-11-14 | 2024-04-16 | 济南悟通生物科技有限公司 | 一种2-乙酰基-5-噻唑甲酸的合成方法 |
| WO2026028053A2 (en) | 2024-07-27 | 2026-02-05 | Assia Chemical Industries Ltd. | Process for the preparation of tovorafenib |
| CN119241530B (zh) * | 2024-09-20 | 2026-04-10 | 武汉九州钰民医药科技有限公司 | 一种Tovorafenib的药物合成工艺 |
| CN119241529B (zh) * | 2024-09-20 | 2026-04-10 | 武汉九州钰民医药科技有限公司 | 一种Tovorafenib的制备方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6764842B2 (en) * | 2001-03-28 | 2004-07-20 | Merck & Co., Inc. | Enantioselective bioreduction for the preparation of integrin receptor antagonist intermediates |
| TW200303304A (en) * | 2002-02-18 | 2003-09-01 | Astrazeneca Ab | Chemical compounds |
| US7754889B2 (en) * | 2004-03-29 | 2010-07-13 | Takasago International Corporation | Optically active transition metal-diamine compound and process for producing optically active alcohol with the same |
| TWI345568B (en) * | 2004-04-02 | 2011-07-21 | Mitsubishi Tanabe Pharma Corp | Tetrahydronaphthyridine derivatives and a process for preparing the same |
| AR067354A1 (es) * | 2007-06-29 | 2009-10-07 | Sunesis Pharmaceuticals Inc | Compuestos utiles como inhibidores de la raf quinasa |
| EP2167497A2 (en) * | 2007-06-29 | 2010-03-31 | Sunesis Pharmaceuticals, Inc. | Heterocyclic compounds useful as raf kinase inhibitors |
| MX351657B (es) * | 2012-03-14 | 2017-10-23 | Merck Sharp & Dohme | Sales de alcaloide de cinchona bis-cuaternarias como catalizadores de transferencia de fase asimétrica. |
| CN107880075A (zh) | 2012-03-28 | 2018-04-06 | 武田药品工业株式会社 | 铑催化剂和制备胺化合物的方法 |
| TWI602803B (zh) * | 2013-03-29 | 2017-10-21 | 第一三共股份有限公司 | 光學活性二胺衍生物之製造方法 |
| WO2015178846A1 (en) * | 2014-05-20 | 2015-11-26 | Sp Process Development Ab | Process for the preparation of chiral amines from prochiral ketones |
| JP6638363B2 (ja) | 2015-12-11 | 2020-01-29 | 株式会社大林組 | 掘削装置および杭孔の拡径方法 |
| CN105524111B (zh) * | 2016-01-25 | 2017-10-27 | 西北农林科技大学 | 手性亚磷酰胺单齿配体及其合成方法与应用 |
| MX391164B (es) | 2017-05-30 | 2025-03-21 | Dot Therapeutics 1 Inc | Metodo para producir compuesto opticamente activo |
-
2018
- 2018-05-29 MX MX2019014256A patent/MX391164B/es unknown
- 2018-05-29 EA EA201992709A patent/EA039880B1/ru unknown
- 2018-05-29 CN CN201880050913.0A patent/CN111032047B/zh active Active
- 2018-05-29 EP EP18808978.3A patent/EP3632441B1/en active Active
- 2018-05-29 KR KR1020197038460A patent/KR102754527B1/ko active Active
- 2018-05-29 AU AU2018276192A patent/AU2018276192B2/en active Active
- 2018-05-29 CA CA3065683A patent/CA3065683A1/en active Pending
- 2018-05-29 ES ES18808978T patent/ES2986461T3/es active Active
- 2018-05-29 EP EP24180862.5A patent/EP4406609A3/en active Pending
- 2018-05-29 US US16/617,914 patent/US10988469B2/en active Active
- 2018-05-29 WO PCT/IB2018/053822 patent/WO2018220533A2/ja not_active Ceased
- 2018-05-29 CN CN202311299784.8A patent/CN117447464A/zh active Pending
- 2018-05-30 JP JP2018103970A patent/JP7102233B2/ja active Active
-
2019
- 2019-11-27 IL IL270983A patent/IL270983B/en unknown
-
2021
- 2021-02-19 US US17/180,127 patent/US12129249B2/en active Active
-
2022
- 2022-05-11 JP JP2022078462A patent/JP7420865B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3632441A2 (en) | 2020-04-08 |
| JP7420865B2 (ja) | 2024-01-23 |
| MX391164B (es) | 2025-03-21 |
| IL270983B (en) | 2022-03-01 |
| US20210347769A1 (en) | 2021-11-11 |
| KR102754527B1 (ko) | 2025-01-14 |
| JP2018203733A (ja) | 2018-12-27 |
| EP4406609A3 (en) | 2024-10-02 |
| AU2018276192A1 (en) | 2020-01-16 |
| AU2018276192B2 (en) | 2022-05-19 |
| EP4406609A2 (en) | 2024-07-31 |
| US20200317659A1 (en) | 2020-10-08 |
| MX2019014256A (es) | 2022-03-31 |
| JP7102233B2 (ja) | 2022-07-19 |
| KR20200013707A (ko) | 2020-02-07 |
| CN117447464A (zh) | 2024-01-26 |
| EP3632441A4 (en) | 2021-01-13 |
| WO2018220533A3 (ja) | 2019-02-28 |
| ES2986461T3 (es) | 2024-11-11 |
| CN111032047A (zh) | 2020-04-17 |
| EA201992709A1 (ru) | 2020-04-23 |
| WO2018220533A2 (ja) | 2018-12-06 |
| EP3632441C0 (en) | 2024-07-17 |
| CN111032047B (zh) | 2023-10-27 |
| BR112019025355A2 (pt) | 2020-06-23 |
| JP2022116043A (ja) | 2022-08-09 |
| US10988469B2 (en) | 2021-04-27 |
| EA039880B1 (ru) | 2022-03-23 |
| US12129249B2 (en) | 2024-10-29 |
| EP3632441B1 (en) | 2024-07-17 |
| IL270983A (en) | 2020-01-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7420865B2 (ja) | 光学活性化合物の製造法 | |
| US11053188B2 (en) | Process for the preparation of enantiomerically and diastereomerically enriched cyclobutane amines and amides | |
| US20130184468A1 (en) | Process for the preparation of propionic acid derivatives | |
| JP2005516036A6 (ja) | 非ラセミｓｙｎ−１−（４−ヒドロキシ−フェニル）−２−（４−ヒドロキシ−４−フェニル−ピペリジン−１−イル）−１−プロパノ−ル化合物の製造方法 | |
| JP2005516036A (ja) | 非ラセミｓｙｎ−１−（４−ヒドロキシ−フェニル）−２−（４−ヒドロキシ−４−フェニル−ピペリジン−１−イル）−１−プロパノ−ル化合物の製造方法 | |
| US20180079741A1 (en) | Process for producing heterocyclic compound | |
| HK40114634A (en) | Method for producing optically active compound | |
| HK40022701A (en) | Method for producing optically active compound | |
| BR112019025355B1 (pt) | Métodos para a produção de compostos oticamente ativos, composto e forma oticamente ativa | |
| HK40022701B (en) | Method for producing optically active compound | |
| RU2793738C2 (ru) | Способ получения энантиомерно и диастереомерно обогащенных циклобутанаминов и -амидов |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20230529 |
|
| D15 | Examination report completed |
Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D15-D126 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: EXAMINER'S REPORT Effective date: 20240802 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - RESPONSE TO EXAMINER'S REQUISITION Effective date: 20241202 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20250214 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 7TH ANNIV.) - STANDARD Year of fee payment: 7 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20250523 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20250523 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT Effective date: 20250605 |
|
| P13 | Application amended |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED Effective date: 20250605 |
|
| D22 | Grant of ip right intended |
Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D22-D128 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: ALLOWANCE REQUIREMENTS DETERMINED COMPLIANT Effective date: 20260326 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20260326 |